Similar articles

• [Regional perfusion therapy of malignant tumors of the extremities].

  Boeckl O, Hell E, Zimmermann G. Boeckl O, et al. Dtsch Med Wochenschr. 1970 Mar 27;95(13):707-10. doi: 10.1055/s-0028-1108531. Dtsch Med Wochenschr. 1970. PMID: 4985407 Review. German. No abstract available.
• [Isolated hyperthermic perfusion of the extremities with cytostatic agents. A method of treatment in malignant melanoma and soft tissue sarcoma].

  Kettelhack C, Schlag P. Kettelhack C, et al. Dtsch Krankenpflegez. 1989 Sep;42(9):597-601. Dtsch Krankenpflegez. 1989. PMID: 2518209 German. No abstract available.
• [Hyperthermia in malignant tumors of the extremities--experimental heating by a radiofrequency applicator and its clinical significance].

  Matsui N, Ohta H, Otsuka T, Hattori M, Sekiya I, Kusada J. Matsui N, et al. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-3):1788-94. Gan To Kagaku Ryoho. 1989. PMID: 2730074 Japanese.
• Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan.

  Hohenberger P, Bida B, Schlag PM. Hohenberger P, et al. Strahlenther Onkol. 1996 Nov;172 Suppl 2:14-5. Strahlenther Onkol. 1996. PMID: 8946039 No abstract available.
• Extremity perfusion for sarcoma.

  Hoekstra HJ. Hoekstra HJ. Surg Oncol Clin N Am. 2008 Oct;17(4):805-24, ix. doi: 10.1016/j.soc.2008.04.006. Surg Oncol Clin N Am. 2008. PMID: 18722920 Review.